title: [Association of genetic polymorphisms in the DNA repair gene XPD with risk of lung and esophageal cancer in a Chinese population in Beijing].
abstract: OBJECTIVE
  XPD polymorphisms at Asp312Asn and Lys751Gln sites have been shown to modulate DNA repair capacity. The authors therefore assessed the relationship between these XPD polymorphisms and susceptibility to lung and esophageal cancer in a Chinese population via a hospital-based, case-control study.
  
  
  METHODS
  Genotypes were determined by PCR-restriction fragment length polymorphism approaches in 383 healthy controls, 351 patients with lung cancer, and 325 patients with esophageal squamous cell carcinoma (SCC). The adjusted odds ratios (OR) and 95% confidence intervals (CI) were calculated using multivariate logistic regression.
  
  
  RESULTS
  Individuals carrying at least one 312Asn variant allele (Asp/Asn and Asn/Asn genotypes) were at an increased risk for lung SCC as compared with those with the Asp/Asp genotype (OR 1.80; 95% CI: 1.10-2.93; adjusted for age, sex and smoking), but this increased risk was not observed among patients with adenocarcinoma of the lung (adjusted OR: 1.07; 95% CI: 0.55-2.08). Furthermore, stratified analysis indicated a multiplicative interaction between tobacco smoking and the variant XPD 312Asn and 751Gln alleles on risk of lung SCC. The ORs of lung SCC for the variant XPD 312Asn and 751Gln alleles with smoking>or=29 pack/year were 12.44 (95% CI: 4.97-31.17) and 10.74 (95% CI: 4.51-25.57), respectively. No significant association between the Asp312Asn or Lys751Gln polymorphism and the risk of esophageal cancer was found.
  
  
  CONCLUSIONS
  The above findings indicate that the Asp312Asn and Lys751Gln polymorphisms in the XPD locus are associated with the risk of lung SCC but not lung adenocarcinoma or esophageal SCC in this Chinese population.
authors.affiliation: Department of Etiology Carcinogenesis, Cancer Institute Hospital Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, PR China.
authors.forename: De-yin
authors.initials: DY
authors.lastname: Xing
authors.forename: Jun
authors.initials: J
authors.lastname: Qi
authors.forename: Wen
authors.initials: W
authors.lastname: Tan
authors.forename: Xiao-ping
authors.initials: XP
authors.lastname: Miao
authors.forename: Gang
authors.initials: G
authors.lastname: Liang
authors.forename: Chun-yuan
authors.initials: CY
authors.lastname: Yu
authors.forename: Wen-fu
authors.initials: WF
authors.lastname: Lu
authors.forename: Chuan-nong
authors.initials: CN
authors.lastname: Zhou
authors.forename: Min
authors.initials: M
authors.lastname: Wu
authors.forename: Dong-xin
authors.initials: DX
authors.lastname: Lin
mesh_terms: D000230:Adenocarcinoma / Q000235:genetics; D001216:Asparagine / Q000235:genetics; D001224:Aspartic Acid / Q000235:genetics; D002294:Carcinoma, Squamous Cell / Q000235:genetics; D002681:China; D004247:DNA / Q000235:genetics; D004265:DNA Helicases; D004260:DNA Repair / Q000235:genetics; D004268:DNA-Binding Proteins; D004938:Esophageal Neoplasms / Q000235:genetics*; D005260:Female; D005787:Gene Frequency; D005838:Genotype; D006801:Humans; D016015:Logistic Models; D008175:Lung Neoplasms / Q000235:genetics*; D008297:Male; D015999:Multivariate Analysis; D016017:Odds Ratio; D011110:Polymorphism, Genetic; D012150:Polymorphism, Restriction Fragment Length; D011506:Proteins / Q000235:genetics*; D012307:Risk Factors; D012907:Smoking; D014157:Transcription Factors; D051759:Xeroderma Pigmentosum Group D Protein
chemical_list: D004268:DNA-Binding Proteins; D011506:Proteins; D014157:Transcription Factors; D001224:Aspartic Acid; D001216:Asparagine; D004247:DNA; D004265:DNA Helicases; D051759:Xeroderma Pigmentosum Group D Protein; C497292:ERCC2 protein, human